NO911138L - Bakterielle vektorer. - Google Patents

Bakterielle vektorer.

Info

Publication number
NO911138L
NO911138L NO91911138A NO911138A NO911138L NO 911138 L NO911138 L NO 911138L NO 91911138 A NO91911138 A NO 91911138A NO 911138 A NO911138 A NO 911138A NO 911138 L NO911138 L NO 911138L
Authority
NO
Norway
Prior art keywords
spee
lactococcus
new
msp
dna
Prior art date
Application number
NO91911138A
Other languages
English (en)
Norwegian (no)
Other versions
NO911138D0 (no
Inventor
Bruno Suri
Albert Schmitz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO911138D0 publication Critical patent/NO911138D0/no
Publication of NO911138L publication Critical patent/NO911138L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/853Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO91911138A 1990-03-22 1991-03-21 Bakterielle vektorer. NO911138L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909006400A GB9006400D0 (en) 1990-03-22 1990-03-22 Bacterial vectors

Publications (2)

Publication Number Publication Date
NO911138D0 NO911138D0 (no) 1991-03-21
NO911138L true NO911138L (no) 1991-09-23

Family

ID=10673033

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911138A NO911138L (no) 1990-03-22 1991-03-21 Bakterielle vektorer.

Country Status (22)

Country Link
US (1) US5559007A (OSRAM)
EP (1) EP0449770B1 (OSRAM)
JP (1) JPH04211384A (OSRAM)
KR (1) KR910016930A (OSRAM)
AR (1) AR245504A1 (OSRAM)
AT (1) ATE174055T1 (OSRAM)
AU (1) AU643511B2 (OSRAM)
BR (1) BR9101137A (OSRAM)
CA (1) CA2038706A1 (OSRAM)
DE (1) DE69130544T2 (OSRAM)
DK (1) DK0449770T3 (OSRAM)
ES (1) ES2125864T3 (OSRAM)
FI (1) FI911367A7 (OSRAM)
GB (1) GB9006400D0 (OSRAM)
HU (1) HUT57263A (OSRAM)
IE (1) IE910948A1 (OSRAM)
MX (1) MX25027A (OSRAM)
NO (1) NO911138L (OSRAM)
NZ (1) NZ237506A (OSRAM)
PT (1) PT97081B (OSRAM)
TW (1) TW213488B (OSRAM)
ZA (1) ZA912114B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286361A (en) * 1992-10-19 1994-02-15 Regents Of The University Of California Magnetically attached sputter targets
AU2149495A (en) * 1995-04-11 1996-10-30 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
EP0925364B1 (en) * 1996-09-06 2002-10-23 Bioteknologisk Institut A lactic acid bacterial regulatable expression system
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
JP2005529622A (ja) 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
CA2506031A1 (en) * 2002-11-15 2004-06-03 Vib Vzw Self-containing lactobacillus strain comprising a thya mutation and therapeutic applications thereof
ES2596855T3 (es) 2005-11-29 2017-01-12 Intrexon Actobiotics Nv Inducción de tolerancia mucosa a antígenos
RU2495129C2 (ru) 2007-01-12 2013-10-10 Актогеникс Н.В. ПРОМОТОРЫ Lactococcus И ИХ ПРИМЕНЕНИЕ:
JP2010516269A (ja) 2007-01-25 2010-05-20 アクトジェニックス・エヌブイ 抗原の粘膜送達による免疫疾患の治療
JP5126879B2 (ja) * 2007-07-13 2013-01-23 独立行政法人海洋研究開発機構 新規dna断片およびそれを含む組換えベクター、それらによって形質転換された形質転換体、ならびにそれらの利用
DK3181682T3 (da) 2008-09-29 2021-07-05 Intrexon Actobiotics Nv Reduceret kolonisering af mikrober på slimhinden
JP5897459B2 (ja) 2009-04-30 2016-03-30 イントレクソン・アクトバイオテイクス・エヌブイIntrexon Actobiotics NV 乳酸菌のフリーズドライのための凍結保護剤
EP2275527A1 (en) 2009-07-17 2011-01-19 ActoGeniX NV Animal component-free culture medium for bacterial fermentation
EP3192873A1 (en) 2009-09-29 2017-07-19 Intrexon Actobiotics NV Lactobacillus and streptococcus promoters and uses thereof
CA2802994A1 (en) 2010-06-17 2011-12-22 The United States Of America As Represented By The Secretary, National I Nstitutes Of Health Compositions and methods for treating inflammatory conditions
RU2644346C2 (ru) 2011-06-01 2018-02-08 Интрексон Актобиотикс Н.В. Система полицистронной экспрессии для бактерий
DK2758512T3 (en) 2011-09-23 2018-07-23 Intrexon Actobiotics Nv MODIFIED GRAM POSITIVE BACTERIES AND APPLICATIONS THEREOF
EP2758513B1 (en) 2011-09-23 2018-05-16 Intrexon Actobiotics NV Modified gram positive bacteria and uses thereof
JP7292877B2 (ja) 2016-01-14 2023-06-19 イントレクソン・アクトバイオテイクス・エヌブイ 1型糖尿病を処置するための組成物および方法
US20200095566A1 (en) * 2017-03-22 2020-03-26 Agency For Science, Technology And Research Protein Expression Construct and Methods Thereof
CN116144690A (zh) * 2022-08-23 2023-05-23 江西省科学院微生物研究所(江西省流域生态研究所) 一种大肠杆菌与乳酸菌的穿梭载体pDXA及构建方法与应用
WO2025233675A1 (en) 2024-05-10 2025-11-13 Institut Pasteur Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings
WO2025253171A1 (en) 2024-06-04 2025-12-11 Institut Pasteur Characterization of viruses associated with the zoonotic fish-borne oncogenic liver flukes and applications thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8400687A (nl) 1984-03-02 1985-10-01 Unilever Nv Recombinant plasmiden; recombinant plasmiden bevattende bacterien; werkwijze voor het bereiden of vervaardigen van een zuivelproduct; werkwijze voor het bereiden van een eiwit.
ATE64956T1 (de) 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
NL8503316A (nl) * 1985-11-29 1987-06-16 Stichting Nl I Zuivelonderzoek Werkwijze voor het bereiden van proteinen met behulp van gastheer-organismen, in het bijzonder melkzuurbacterien, welke recombinant dna-plasmiden met een hoge replicon-aktiviteit en een hoge promotor-aktiviteit voor het betreffende proteine-coderende gen bevatten, de van dergelijke recombinant dna-plasmiden voorziene gastheerorganismen, de recombinant dna-plasmiden zelve, de replicon-aktiviteit en promotor-aktiviteit coderende dna-fragmenten, alsmede de verkregen proteinen.
EP0316677A3 (en) 1987-11-13 1990-04-25 Miles Inc. Method for cloning in lactic acid bacteria
NL9000753A (nl) * 1990-03-30 1991-10-16 Nl Zuivelonderzoek Inst Dna-fragment, ten minste coderend voor een deel van het extracellulaire eiwit met een schijnbaar molecuulgewicht van 60 kda van lactococcus lactis stammen zoals de lactococcus lactis ssp. lactis stam mg1363, combinaties hiervan met voor homologe of heterologe eiwitten coderende dna-sequenties alsmede de hiermee verkregen homologe en heterologe eiwitten.

Also Published As

Publication number Publication date
KR910016930A (ko) 1991-11-05
ATE174055T1 (de) 1998-12-15
TW213488B (OSRAM) 1993-09-21
AU643511B2 (en) 1993-11-18
CA2038706A1 (en) 1991-09-23
PT97081B (pt) 1998-07-31
BR9101137A (pt) 1991-11-05
AR245504A1 (es) 1994-01-31
EP0449770B1 (en) 1998-12-02
IE910948A1 (en) 1991-09-25
FI911367A0 (fi) 1991-03-20
PT97081A (pt) 1991-11-29
US5559007A (en) 1996-09-24
AU7355891A (en) 1991-10-03
HUT57263A (en) 1991-11-28
DK0449770T3 (da) 1999-06-23
DE69130544D1 (de) 1999-01-14
NZ237506A (en) 1992-12-23
EP0449770A3 (en) 1992-07-01
FI911367L (fi) 1991-09-23
HU910958D0 (en) 1991-10-28
GB9006400D0 (en) 1990-05-23
DE69130544T2 (de) 1999-04-29
ES2125864T3 (es) 1999-03-16
ZA912114B (en) 1992-01-29
FI911367A7 (fi) 1991-09-23
NO911138D0 (no) 1991-03-21
EP0449770A2 (en) 1991-10-02
MX25027A (es) 1993-12-01
JPH04211384A (ja) 1992-08-03

Similar Documents

Publication Publication Date Title
NO911138L (no) Bakterielle vektorer.
Brawner et al. Streptomyces: a host for heterologous gene expression
Doi et al. Potential use of Bacillus subtilis for secretion and production of foreign proteins
IL115834A0 (en) Process for bacterial production of polypeptides
DK1356073T3 (da) Fermenteringsfremgangsmåde til fremstilling af heterologe genprodukter i mælkesyrebakterier
ES8306796A1 (es) "un metodo de crear un microorganismo capaz de producir una proteina predeterminada por expresion".
ES8307297A1 (es) Proceso para la produccion microbiana de interferon fibro- blasto humano
FI871919A0 (fi) Sekretionssignalselektionsvektorer foer extracellulaer proteinsyntes hos bacillus-bakterier.
AU627648B2 (en) Dna fragment encoding a polypeptide having nitrile hydratase activity, a transformant containing the gene and a process for the production of amides using the transformant
CA2346797A1 (en) Process for recovering heterologous polypeptides from bacterial cells
EG19101A (en) Process for preparing of expression of human proapolipoprotein A.1.
DK82293D0 (da) Normalt sporulerende bacillus uden evne til at udskille subtilisin eller neutral protease, kulturer deraf og fremgangsmaade til fremstilling af heterologe proteiner dermed
PL291226A1 (en) Purified and isolated dna sequence encoding a polypeptide of xylanase activity and method of obtaining such sequence; dna expression structure, method of obtaining same, transformed host of microbial origin and method of obtaining same; method of xylanase activity polypeptide hyperexpression, polypeptide of xsylanase activity and application of such polypeptide; animal feed and method of obtaining same; dough for baking bread; method of degradating products containing xylanes ...
IL80022A (en) Cloned human basic fibroblast growth factor, methods for its preparation, compositions containing it, dna sequences encoding therefor and vectors and host cells containing said dna
FI950628A0 (fi) Modifioidut sienisolut ja menetelmä rekombinanttituotteiden tuottamiseksi
DE69130872D1 (de) Sekretionsvektor, diesen enthaltene transformierte Mikroorganismen und Herstellung von Produkten durch obigen Mikroorganismus
EP0546049B1 (en) A method for rapid selection of efficient secretion vectors
Rintala et al. Biosynthesis of nisin in the subtilin producer Bacillus subtilis ATCC6633
FI824238L (fi) Foerfarande och vektororganism foer ackumulering av klonade heterologa genprodukter reglerat i bacillus subtilis ii
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
IL94422A0 (en) Saf polypeptide,gene coding therefor,saf promoter and expression methods for expressing foreign dna sequences in streptomyces
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
ECSP910731A (es) Vectores bacteriales
HUP9903959A2 (hu) Csonkított vérlemezke-aktiváló faktor acetilhidroláz
Kakudo et al. Secretory expression of a glutamic-acid-specific endopeptidase (SPase) from Staphylococcus aureus ATCC12600 in Bacillus subtilis